<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="UTF-8">
  <meta http-equiv="X-UA-Compatible" content="IE=edge">
  <meta name="viewport" content="width=device-width, initial-scale=1.0">
  <link rel="shortcut icon" href="../images/favicon.png" type="image/x-icon">
  <title>Tetanus</title>
  <link href="https://cdn.jsdelivr.net/npm/remixicon@2.5.0/fonts/remixicon.css" rel="stylesheet">
  <link rel="stylesheet" href="../style.css">
  <link rel="stylesheet" href="../notes.css">

</head>
<body>
  <input type="checkbox" id="main-navigation-toggle" class="btn btn--close" title="Toggle main navigation" />
  <label for="main-navigation-toggle">
    <span></span>
  </label>
  
  <a href="../index.html">
   <div class="home-navigation">
      mtr<span class="logo-dot">.</span>
    </div>
  </a>


    <nav id="main-navigation" class="nav-main">
    <ul class="menu">
      <li class="menu__item">
        <a class="menu__link" href="../index.html">Home</a>
      </li>

      <li class="menu__item">
        <a class="menu__link" href="../about-temp2.html">About</a>
      </li>
    </ul>
  </nav>
  
      <!-- Toggle switch for dark mode -->
      <div class="dark-mode-toggle">
        <label class="switch-toggle">
            <input type="checkbox" id="dark-mode-toggle-checkbox">
            <span class="toggle-slider"></span>
        </label>
      </div>

      <!-- Progress Bar  -->
      <div id="progress-container">
        <div id="progress-bar"></div>
    </div>
      
<!-- SIDEBAR -->
<div id="sidebar" class="sidebar">
  <button id="closeSidebarBtn" class="btn toggle-btn close-btn">Close</button>
  <ul class="sidebar-menu toggle-menu">
    <!-- Add the list of topics dynamically using JavaScript -->
  </ul>
</div>

<!-- Toggle button to open the sidebar -->
<button id="toggleSidebarBtn" class="btn toggle-btn">&#9776;</button>

<!-- END OF SIDEBAR -->

  <main class="page-container">
    <div class="contribute-cta">
      <p>Help make this betterüíú</p>
      <span><a href="../contribute.html">Contribute here</a> </span>
    </div>


  <!-- TOPIC AND IMAGE CONTAINER  -->


      <h1>Tetanus</h1>


  <!-- END OF TOPIC AND IMAGE CONTAINER  -->
  


    <article class="notes">
        <a id='top'></a>
    <article>

          <!-- LEARNING OBJECTIVES CONTAINER  -->
              <!-- <div class="custom-card" id="custom-card-1">
                <div class="icon"><img src="../images/icons/light-bulb.png" alt="Icon" class="icon"></div>
                <div class="title"> 
                  <h2>What You Will Learn</h2>
                </div>
                <div class="line">
                  <p>After reading this note, you should be able to...</p>
                </div>
                <div class="content">
                  <ul>
                    <li><i>This content is not available yet.</i></li>
                </ul>
                </div>
                <div class="read-more" onclick="toggleContent('custom-card-1')">Read More üç™</div>
              </div> -->
            
          <!-- END OF LEARNING OBJECTIVES CONTAINER  -->
        
        
          <!-- SHOW AND HIDE OUTLINE CONTAINER  -->
            <div class="outline2">
        
              <input type="radio" name="control-2" id="show-2">
              <label for="show-2">üêµ&nbsp; &nbsp;Show Outline</label>
              <input type="radio" name="control-2" id="hide-2">
              <label for="hide-2">üôà&nbsp; &nbsp; Hide Outline</label>
              <div class="contents">
                <div class="icon-box">
                  <!-- Replace 'path/to/your/icon.png' with the actual path to your PNG icon -->
                  <img src="../images/icons/book.png" alt="Icon" class="icon">
                </div>
                <div id="tableOfContents">
                    <ol id="tocList"></ol>
                </div>
              </div>
             <div>
        
        <!-- END OF SHOW AND HIDE OUTLINE CONTAINER  -->
        
        
<br>
        
            <!-- BEGINNING OF NOTE -->
        
      <section id='header-1'>
        <header>
          <h2>
            <a aria-hidden='true' href='#header-1'>Introduction</a>
          </h2>
        </header>
        <div class='body'>
          <ul>
            <li>Tetanus is a neurological disorder characterized by increased muscle tone and spasms, that is caused by <strong>tetanospasmin</strong>, a powerful protein toxin elaborated by <strong>Clostridium tetani</strong>.</li>

            <li>1st described ‚Äì Egypt 3000 years ago.</li>
            <li>1st passive immunization - 1893.</li>
            <li>800,000 - 1 million deaths/year.</li>
            <li>400,000 - Neonatal.</li>
            <li>80% of deaths occur in Africa & SE Asia.</li>
            <li>Remains endemic in 90 countries worldwide.</li>
          </ul>
          
          <p><strong>Clinical forms-</strong></p>
          <ul>
            <li>Generalized</li>
            <li>Localized</li>
            <li>Cephalic</li>
            <li>Neonatal</li>
          </ul>
        </div>
      </section>

      <section id='header-2'>
        <header>
          <h2>
            <a aria-hidden='true' href='#header-2'>Etiology</a>
          </h2>
        </header>
        <div class='body'>
          <ul>
            <li><strong>C. tetani</strong></li>
            <li>Obligate anaerobe, motile, spore-forming, G +ve bacillus.</li>
            <li>Spores can withstand boiling for 20 min.</li>
            <li>Widely distributed in the environment.</li>
            <li>Found in the intestinal flora of domestic animals, horses, chickens, and humans.</li>
            <li>Toxins: <strong>tetanolysin</strong> & <strong>tetanospasmin</strong>.</li>
          </ul>
          

        </div>
      </section>

      <section id='header-3'>
        <header>
          <h2>
            <a aria-hidden='true' href='#header-3'>Epidemiology</a>
          </h2>
        </header>
        <div class='body'>
          <ul>
            <li><strong>Worldwide</strong></li>
            <li>Tetanus cases in the United States has declined significantly since 1947. This is likely due to the widespread use of tetanus vaccines.</li>
            <li>Sporadic</li>
            <li>Almost always affects <strong>non-immunized</strong></li>
            <li>Partially immunized</li>
            <li>Fully immunized who fail to maintain adequate immunity with booster doses of vaccine</li>
            <li>Common in:</li>
            <ul>
              <li>Rural areas</li>
              <li>Warm climates</li>
              <li>Summer months</li>
              <li>Male</li>
            </ul>
          </ul>
          
        </div>
      </section>

      <section id='header-4'>
        <header>
          <h2>
            <a aria-hidden='true' href='#header-4'>Pathogenesis</a>
          </h2>
        </header>
        <div class='body'>
          <ul>
            <li><strong>C. tetani</strong> spores usually enter through contaminated wounds.</li>
            <li>Manifestations of tetanus are caused by an exotoxin (<strong>tetanospasmin</strong>) produced when bacteria lyse. The toxin enters peripheral nerve endings, binds there irreversibly, then travels retrograde along the axons and synapses, and ultimately enters the central nervous system (CNS).</li>
            <li>As a result:
              <ul>
                <li>Release of inhibitory transmitters from nerve terminals is blocked, causing unopposed muscle stimulation by acetylcholine and generalized tonic spasticity.</li>
                <li>This typically leads to superimposed intermittent tonic seizures.</li>
                <li>Disinhibition of autonomic neurons and loss of control of adrenal catecholamine release cause autonomic instability and a hypersympathetic state.</li>
                <li>Once bound, the toxin cannot be neutralized.</li>
              </ul>
            </li>
            <li>Most often, tetanus is generalized, affecting skeletal muscles throughout the body. However, tetanus is sometimes localized to muscles near an entry wound.</li>
          </ul>
          
        </div>
      </section>

      <section id='header-5'>
        <header>
          <h2>
            <a aria-hidden='true' href='#header-5'>Clinical Features</a>
          </h2>
        </header>
        <div class='body'>
          <h4>Symptoms of Tetanus</h4>
          <ul>
            <li>The incubation period ranges from <strong>2 to 50 days</strong> (average, <strong>5 to 10 days</strong>).</li>
            <li>Symptoms of tetanus include:</li>
            <ul>
              <li>Jaw stiffness (most frequent)</li>
              <li>Difficulty swallowing</li>
              <li>Restlessness</li>
              <li>Irritability</li>
              <li>Stiff neck, arms, or legs</li>
              <li>Arching of the back (opisthotonos)</li>
              <li>Headache</li>
              <li>Sore throat</li>
              <li>Tonic spasms</li>
            </ul>
            <li>Later, patients have difficulty opening their jaw (<strong>trismus</strong>).</li>
          </ul>
          
          <h4>Spasms</h4>
          <ul>
            <li>Facial muscle spasm produces a characteristic expression with a fixed smile and elevated eyebrows (<strong>risus sardonicus</strong>).</li>
            <li>Rigidity or spasm of abdominal, neck, and back muscles and sometimes <strong>opisthotonos</strong> (generalized rigidity of the body with arching of the back and neck) may occur.</li>
            <li>Sphincter spasm causes urinary retention or constipation.</li>
            <li>Dysphagia may interfere with nutrition.</li>
            <li>Characteristic painful, generalized tonic spasms with profuse sweating are precipitated by minor disturbances such as a draft, noise, or movement.</li>
            <li>Mental status is usually clear, but coma may follow repeated spasms.</li>
            <li>During generalized spasms, patients are unable to speak or cry out because of chest wall rigidity or glottal spasm.</li>
            <li>Rarely, fractures result from sustained spasms.</li>
            <li>Spasms also interfere with respiration, causing cyanosis or fatal asphyxia.</li>
          </ul>
          

          <h4>Autonomic Instability</h4>
          <ul>
            <li>Temperature is only moderately elevated unless a complicating infection, such as pneumonia, is present.</li>
            <li>Respiratory and pulse rates are increased.</li>
            <li>Reflexes are often exaggerated.</li>
            <li>Protracted tetanus may manifest as a very labile and overactive sympathetic nervous system, including periods of:</li>
            <ul>
              <li>Hypertension</li>
              <li>Tachycardia</li>
              <li>Myocardial irritability</li>
            </ul>
          </ul>
          
          <h4>Causes of Death</h4>
          <ul>
            <li>Respiratory failure is the most common cause of death. Laryngeal spasm and rigidity and spasms of the abdominal wall, diaphragm, and chest wall muscles cause asphyxiation.</li>
            <li>Hypoxemia can also induce cardiac arrest, and pharyngeal spasm leads to aspiration of oral secretions with subsequent pneumonia, contributing to a hypoxemic death.</li>
            <li>Pulmonary embolism is also possible.</li>
            <li>However, the immediate cause of death may not be apparent.</li>
          </ul>
          

          <h4>Localized Tetanus</h4>
          <ul>
            <li>In localized tetanus, there is spasticity of muscles near the entry wound but no trismus; spasticity may persist for weeks.</li>

            <li><strong>Cephalic tetanus</strong> is a form of localized tetanus that affects the cranial nerves. It is more common among children; in them, it may occur with chronic otitis media or may follow a head wound.</li>
            <li>Incidence is highest in Africa and India.</li>
            <li>All cranial nerves can be involved, especially the 7th.</li>
            <li>Cephalic tetanus may become generalized.</li>
          </ul>
          

          <h4>Tetanus Neonatorum (Neonatal Tetanus)</h4>
          <ul>
            <li>Tetanus in neonates is usually generalized and frequently fatal. It often begins in an inadequately cleansed umbilical stump in children born of inadequately immunized mothers.</li>
            <li>Onset during the first 2 weeks of life is characterized by:
              <ul>
                <li>Rigidity</li>
                <li>Spasms</li>
                <li>Poor feeding</li>
              </ul>
            </li>
            <li>Bilateral deafness may occur in surviving children.</li>
          </ul>
          
          
        </div>
      </section>

      <section id='header-6'>
        <header>
          <h2>
            <a aria-hidden='true' href='#header-6'>Severity Grading</a>
          </h2>
        </header>
        <div class='body'>
          <p><strong>Classification</strong></p>
          <ul>
            <li>Ablett's Classification of Tetanus Severity</li>
            <li>APACHE II Score</li>
            <li>Bademosi/Oshuntokun</li>
          </ul>
          
          <p><strong>Mild</strong> - spasm</p>
          <p><strong>Moderate</strong> - contact/reflex spasm</p>
          <p><strong>Severe</strong> - spontaneous spasm</p>
          <p><strong>Very Severe</strong> - status spasm/laryngospasm/apnoeic spells</p>
          
          <h4>Rating Scale</h4>
          <p><strong>1 point is given for each of the following:</strong></p>

          <ul>
            <li>Incubation period shorter than 7 days</li>
            <li>Period of onset shorter than 48 hours</li>
            <li>Tetanus acquired from burns, surgical wounds, compound fractures, septic abortion, umbilical stump, or intramuscular injection</li>
            <li>Narcotic addiction</li>
            <li>Generalized tetanus</li>
            <li>Temperature higher than 104¬∞F (40¬∞C)</li>
            <li>Tachycardia exceeding 120 beats/min (150 beats/min in neonates)</li>
          </ul>
          
          <h4>Severity and Prognosis</h4>
          <p><strong>The total score indicates disease severity and prognosis as follows:</strong></p>

          <ul>
            <li>0 or 1 ‚Äì Mild tetanus; mortality below 10%</li>
            <li>2 or 3 ‚Äì Moderate tetanus; mortality of 10-20%</li>
            <li>4 ‚Äì Severe tetanus; mortality of 20-40%</li>
            <li>5 or 6 ‚Äì Very severe tetanus; mortality above 50%</li>
            <li>Cephalic tetanus is always severe or very severe. Neonatal tetanus is always very severe.</li>
          </ul>

          <br>

          <table class="note-table">
            <thead>
              <tr>
                <th scope="col">Score</th>
                <th scope="col">Severity</th>
                <th scope="col">Prognosis (mortality rate)</th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td>0-1</td>
                <td>mild</td>
                <td>&lt; 10%</td>
              </tr>
              <tr>
                <td>2-3</td>
                <td>moderate</td>
                <td>10-20%</td>
              </tr>
              <tr>
                <td>4</td>
                <td>severe</td>
                <td>20-40</td>
              </tr>
              <tr>
                <td>5-6</td>
                <td>very severe</td>
                <td>&gt; 50%</td>
              </tr>
            </tbody>
          </table>
          


          <br>

          <table class="note-table">
            <tr>
              <th colspan="2">Ablett Classification of Tetanus Severity</th>
            </tr>
            <tr>
              <th>Grade</th>
              <th>Clinical features</th>
            </tr>
            <tr>
              <td>I</td>
              <td>Mild: mild to moderate trismus; general spasticity; no respiratory embarrassment [respiratory distress]; no spasms; little or no dysphagia</td>
            </tr>
            <tr>
              <td>II</td>
              <td>Moderate: moderate trismus; well-marked rigidity; mild to moderate but short spasms; moderate respiratory embarrassment with an increased respiratory rate greater than 30 [breaths/min]; mild dysphagia</td>
            </tr>
            <tr>
              <td>III</td>
              <td>Severe: severe trismus; generalized spasticity; reflex prolonged spasms; increased respiratory rate greater than 40 [breaths/min]; apneic spells; severe dysphagia; tachycardia greater than 120 [beats/min]</td>
            </tr>
            <tr>
              <td>IV</td>
              <td>Very severe: grade III and violent autonomic disturbances involving the cardiovascular system; severe hypertension and tachycardia alternating with relative hypotension and bradycardia, either of which may be persistent</td>
            </tr>
          </table>
          
          <br>

          <table class="note-table">
            <thead>
              <tr>
                <th colspan="3">Prognostic scoring systems in tetanus Dakar score</th>
              </tr>
              <tr>
                <th scope="col">Prognostic Factors</th>
                <th scope="col">Score 1</th>
                <th scope="col">Score 0</th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <th scope="row">Incubation period</th>
                <td>< 7 days</td>
                <td>‚â• 7 days</td>
              </tr>
              <tr>
                <th scope="row">Period of onset</th>
                <td>< 48 h</td>
                <td>‚â• 48 h</td>
              </tr>
              <tr>
                <th scope="row">Portal of entry</th>
                <td>Umbilicus, Burns, Uterine, Open fracture, Surgical wound, Intramuscular injection</td>
                <td>All others</td>
              </tr>

              <tr>
                <th scope="row">Spasms</th>
                <td>Present</td>
                <td>Absent</td>
              </tr>
              <tr>
                <th scope="row">Fever</th>
                <td>> 38,4¬∞C (101.12 ¬∞F)</td>
                <td>‚â§ 38,4¬∞C (101.12 ¬∞F)</td>
              </tr>
              <tr>
                <th scope="row" rowspan="2">Tachycardia</th>
                <td>Adult >120 beats/min</td>
                <td>Adult < 120 beats/min</td>
              </tr>
              <tr>
                <td>Neonate &gt; 150 beats/min</td>
                <td>Neonate < 150 beats/min</td>
              </tr>
            </tbody>
          </table>
          
          
        </div>
      </section>

      <section id='header-7'>
        <header>
          <h2>
            <a aria-hidden='true' href='#header-7'> Management</a>
          </h2>
        </header>
        <div class='body'>
          <ul>
            <li><strong>Diagnosis:</strong> The diagnosis of tetanus is often clinical, by recognition of a triad of <strong>trismus</strong>, <strong>ridus sardonicus</strong>, and <strong>opisthotonus</strong>.</li>
            <li><strong>Principles of Management:</strong> Provide supportive care, particularly respiratory support until the Tetanospasmin that is fixed in tissue has been metabolized.</li>
            <ol>
              <li>Neutralize circulating toxin: ATS (Antitoxin Serum)</li>
              <li>Remove the source of toxin: antibiotics</li>
              <li>Muscle relaxant: diazepam</li>
              <li>Fluids and calories</li>
              <li>Nursing care</li>
              <li>Active immunization (stat, first month, 6th month)</li>
            </ol>
          </ul>
          
          <h4>Treatment of Tetanus</h4>
          <ul>
            <li>Treatment of tetanus requires maintaining adequate ventilation.</li>
            <li>Early and adequate use of human tetanus immune globulin (TIG) to neutralize nonfixed toxin.</li>
            <li>Prevention of further toxin production.</li>
            <li>Sedation.</li>
            <li>Control of muscle spasm and hypertonicity.</li>
            <li>Management of fluid balance and intercurrent infection.</li>
            <li>Continuous nursing care.</li>
            <li>IV immune globulin (IVIG), which contains tetanus antitoxin, may be used if TIG is not available.</li>
          </ul>
          

          <h4>Antitoxin and Toxoid</h4>
          <ul>
            <li>The benefit of <strong>human-derived antitoxin</strong> depends on how much <strong>tetanospasmin</strong> is already bound to the synaptic membranes‚Äîonly <strong>free toxin</strong> is neutralized.</li>
            <li>For adults, <strong>TIG 500 units IM once</strong> appears as effective as higher doses ranging from <strong>3000 to 7000 units</strong> and causes less discomfort.</li>
            <li>Some medical experts recommend infiltration of part of the dose locally around the wound, but its efficacy has not been proved.</li>

            <li><strong>Antitoxin of animal origin</strong>, e.g. equine, is far less preferable because it does not maintain the patient‚Äôs serum antitoxin level well and risk of serum sickness is considerable.</li>
            <li>If horse serum must be used, the usual dose is <strong>10,000 units IM or IV</strong>.</li>
          </ul>
          <p>Intrathecal or Intramuscular?</p>
          <ul>
            <li><strong>RCT-120 Patients:</strong> Intrathecal shows better clinical progression than Intramuscular.</li>
          </ul>
          
          <h4>Wound Care</h4>
          <ul>
            <li>Because dirt and dead tissue promote <strong>C. tetani</strong> growth, prompt, thorough debridement, especially of deep puncture wounds, is essential.</li>
            <li>Antibiotics are not substitutes for adequate debridement and immunization but typically are given.</li>
          </ul>
          

          <h4>Control of Muscle Spasm</h4>
          <ol>
            <li>Diazepam
              <ul>
                  <li>Benzodiazepines block reuptake of an endogenous inhibiting neurotransmitter, gamma-aminobutyric acid (GABA), at the GABAA receptor.</li>
                  <li>Diazepam can help control seizures, counter muscle rigidity, and induce sedation.</li>
                  <li>Dosage varies and requires meticulous titration and close observation.</li>
                
              </ul>
            </li>
            <li>Baclofen - IM, IV, intrathecal - efficacious*</li>
            <li>Propofol</li>
            <li>Dantrolene</li>
            <li>Magnesium sulphate
              <ul>
                <li>Sri Lanka ‚Äì 8 patients - clearly demonstrated efficacy</li>
                <li>No diazepam, muscle relaxant, or ventilatory support</li>
                <li>Therapeutic range - 2-4 mmol</li>
                <ul>
                  <li>4 mmol- areflexia</li>
                  <li>6 mmol- paralysis</li>
                </ul>
              </ul>
            </li>
            <li>Chlorpromazine</li>
          </ol>
          <p>You must check deep tendon reflexes - depressed = toxicity</p>
          

          <h4>Respiratory Care</h4>
          <ul>
            <li>Intubation/Tracheostomy +/- Mechanical Ventilation</li>
          </ul>
          

          <h4>Autonomic Dysfunction</h4>
          <ul>
            <li>Labetalol, esmolol- Beta-blockade is used to control episodes of hypertension and tachycardia.</li>
            <li>Magnesium sulphate, clonidine, lorazepam, morphine</li>
            <ul>
              <li>Magnesium sulfate has a stabilizing effect, eliminating catecholamine stimulation. Patellar tendon reflex is used to assess overdosage</li>
            </ul>
            <li>Hypotension - volume expanders, vasoconstrictors</li>
            <li>Bradycardia - pacemaker</li>
          </ul>
          
          <h4>Antibiotics</h4>
          <ul>
            <li>Penicillin, <strong>Metronidazole</strong>, Erythromycin, Tetracycline, Vancomycin</li>
            <li>Metronidazole vs Penicillin Johnson and Walker - convulsion</li>
            <li>Structure of Penicillin Ahmadsya & Salim - reduction in Mortality in Metronidazole group (7% vs 24%)</li>
            <li>Yen et al - 1000 patients - No significant difference</li>
            <li>*Metronidazole group requires less sedative & muscle relaxant</li>
          </ul>
          
          <h4>Additional Measures</h4>
          <ul>
            <li>IV fluid</li>
            <li>Nutrition</li>
            <li>Physiotherapy</li>
            <li>Anticoagulation, etc.</li>
          </ul>
          
        </div>
      </section>

      <section id='header-8'>
        <header>
          <h2>
            <a aria-hidden='true' href='#header-8'> Prognosis</a>
          </h2>
        </header>
        <div class='body'>
          <ul>
            <li>10-60% Outcome is poor in: elderly, neonate, short incubation period & period of onset.</li>
            <li>Prognostic scoring system in tetanus:
              <ol>
                <li>Dakar score</li>
                <li>Philip score</li>
                <li>Bademosi</li>
              </ol>
            </li>
          </ul>
          
        </div>
      </section>

      <section id='header-9'>
        <header>
          <h2>
            <a aria-hidden='true' href='#header-9'> Complications</a>
          </h2>
        </header>
        <div class='body'>
          <ul>
            <li>Fracture</li>
            <li>Respiratory failure</li>
            <li>Myoglobinuria</li>
            <li>Renal failure</li>
            <li>Intercurrent infections</li>
            <li>DVT/PTE (Deep Vein Thrombosis/Pulmonary Thromboembolism)</li>
            <li>Contractures</li>
          </ul>
          
        </div>
      </section>


      <section id='header-10'>
        <header>
          <h2>
            <a aria-hidden='true' href='#header-10'> Differential Diagnosis</a>
          </h2>
        </header>
        <div class='body'>
          <ul>
            <li>Strychnine poisoning</li>
            <li>Alveolar abscess</li>
            <li>Dystonic drug reaction</li>
            <li>Tetany</li>
            <li>Rabies</li>
            <li>Meningitis</li>
            <li>Stiff-person syndrome</li>
          </ul>
          
        </div>
      </section>





      <hr style="margin: 3rem 0;">

      <!-- PRACTICE QUESTIONS CONTAINER -->

      <!-- <div class="custom-card" id="custom-card-2">
        <div class="icon"><img src="../images/icons/practice-questions.png" alt="Icon" class="icon"></div>
        <div class="title"> 
          <h2>Practice Questions</h2>
        </div>
        <div class="line">
          <p>Check how well you grasp the concepts by answering the following questions...</p>
        </div>
        <div class="content">
          <ol>
            <li><i>This content is not available yet.</i></li>
          </ol>
        </div>
        <div class="read-more" onclick="toggleContent('custom-card-2')">Read More üç™</div>
      </div> -->

      <!-- END OF PRACTICE QUESTIONS CONTAINER -->


      <!-- CONTACT- COMMENT AND CONTRIBUTORS CONTAINER -->
      <div class="contact">
        <div class="comment-container">
          <div class="comment-icon">
            <!-- Add your icon image here -->
            <img src="../images/icons/comment.png" alt="Comment Icon">
          </div>
          <div class="comment-text">
            <!-- Add your text here -->
            <p>Send your comments, corrections, explanations/clarifications and requests/suggestions </p>
          </div>
          <a href="https://chat.whatsapp.com/FtDdb6uEFYzBCnTnMgm2Z1" class="comment-button">
            here
            <img src="../images/icons/whatsapp.png" alt="Image Icon">
          </a>
        </div>

        <div class="contributors-container">

          <!-- <h2 class="contributors-header">Contributors</h2>
  
        <br>
            <div class="contributor-box">
                <img class="contributor-avatar" src="../images/icons/woman.png" alt="Contributor 1 Avatar">
                <div class="contributor-info">
                    <h3 class="contributor-name">Jane Smith</h3>
                    <p class="contributor-description">She is not a real contributor.</p>
                    <div class="social-links">
                        <a href="#" target="_blank" class="social-icon">
                            <img src="../images/icons/whatsapp.png" alt="Social Icon 1">
                        </a>
                        <a href="#" target="_blank" class="social-icon">
                            <img src="../images/icons/twitter.png" alt="Social Icon 2">
                        </a>
                    </div>
                </div>
            </div>
        
            <div class="contributor-box">
                <img class="contributor-avatar" src="../images/icons/man.png" alt="Contributor 2 Avatar">
                <div class="contributor-info">
                    <h3 class="contributor-name">John Doe</h3>
                    <p class="contributor-description">He is not a real contributor.</p>
                    <div class="social-links">
                      <a href="#" target="_blank" class="social-icon">
                        <img src="../images/icons/whatsapp.png" alt="Social Icon 1">
                    </a>
                    <a href="#" target="_blank" class="social-icon">
                        <img src="../images/icons/linkedin.png" alt="Social Icon 2">
                    </a>
                    </div>
                </div>
            </div> -->
        
        </div>
      </div>

            <!-- END OF CONTACT- COMMENT AND CONTRIBUTORS CONTAINER -->
    </article>
   </article>
   <div style="height: 300px;"></div>
  </main>

  <footer>
    <div class="footer-container">
        <div>
          <p id="popup-trigger">disclaimer</p>

          <!-- The pop-up dive content -->
          <div id="popup" class="popup">
            <p>The contents on this ‚Äòwebsite‚Äô are for educational purposes only. The creators and operators of this website make no warranties, express or implied, regarding the accuracy, currency, or completeness of the information provided on the website. They shall not be held responsible for any errors or omissions, or for any actions taken based on the information provided on this website.</p>
            <button class="popup-close" onclick="closePopup()">Close</button>
          </div>    
          <p><a href="../about-temp2.html">about</a> </p>   
          <p><a href="../contribute.html">contribute</a> </p>
          <p><a href="https://chat.whatsapp.com/FtDdb6uEFYzBCnTnMgm2Z1">say hiüëã</a> </p>
        </div>

        <div class="footer-beta">
          <p>thisisatestversion</p>
        </div>
    </div>
  </footer>
<!------------  SCROLL UP ----------->
<a href="#" class="scrollup" id="scroll-up"> 
  <i class="ri-arrow-up-fill scrollup__icon"></i>
</a>
<script src="../main.js"></script>
<script src="../modal.js"></script>
<script src="../notes-sidebar.js"></script>
</body>
</html>
 
